News

XOMA and LAVA Therapeutics Reveal Purchase Agreement Amendments

XOMA and LAVA Therapeutics Reveal Purchase Agreement Amendments

Amendments to the Purchase Agreement Between XOMA and LAVA

XOMA Royalty Corporation (NASDAQ: XOMA) and LAVA Therapeutics N.V. (NASDAQ: LVTX) have recently made significant amendments to their earlier announced definitive share purchase agreement. This collaborative effort aims to beneficially adjust the financial structure of the agreement, ensuring both companies can meet their strategic goals.

Key Changes in Cash Offer for LAVA Shareholders

As part of the amendments, LAVA shareholders who decide to tender their shares will now receive an adjusted initial cash amount of $1.04 per share. This adjustment compares to the previously anticipated cash amount that ranged between $1.16 and $1.24 per share. Additionally, there’s an incorporation of a non-transferable contingent value right (CVR), which will provide rights to certain cash payments that include a percentage of net proceeds from LAVA’s partnered assets and potential future unpartnered programs. This amendment signifies a nuanced understanding of the potential financial obligations and the current state of LAVA's cash reserves.

Extension of Tender Offer Timeline

The tender offer, initially set to expire after October 17, 2025, has now been extended to November 12, 2025. This extension allows shareholders additional time to consider the offer while ensuring that the acquisition process aligns with closing expectations set for the fourth quarter of 2025.

Important Provisions and Shareholder Conditions

The amended purchase agreement introduces several pivotal conditions that need to be satisfied for the deal's consummation. Notably, the tender of at least 80% of LAVA's outstanding shares and other customary closing conditions will be essential. Importantly, LAVA shareholders who previously tendered their shares are not required to retender or take further action due to this latest extension.

The Role of the Extraordinary General Meeting

LAVA has set a new date for its Extraordinary General Meeting (EGM) to discuss and seek approval for essential resolutions related to these transactions. The EGM is scheduled for November 7, 2025, and the gathering offers a formal platform for shareholders to engage with the proposed changes and ensure they align with shareholder interests.

About XOMA Royalty Corporation

XOMA Royalty Corporation operates as a biotechnology royalty aggregator, aiding biotech companies in achieving their objectives to enhance human health. By acquiring the potential future revenue from pre-commercial and commercial therapeutic candidates, XOMA provides a lifeline of non-dilutive and non-recourse funding which supports the further development of internal drug candidates or general corporate purposes. This strategy positions XOMA as a crucial player in the biotechnology sector, fostering innovation while ensuring stakeholders see value in their investments.

About LAVA Therapeutics

LAVA Therapeutics N.V. is a cutting-edge biopharmaceutical organization focused on the development of bispecific gamma delta T cell engagers through its Gammabody platform. Their flagship products work in targeting various cancer types, reflecting a commitment to advancing therapeutic solutions in oncology. LAVA's partnerships with industry giants highlight their potential impact and relevance in the biopharmaceutical landscape.

Frequently Asked Questions

What are the key terms of the purchase agreement amendment between XOMA and LAVA?

The amendment includes a revised cash offer for LAVA shareholders and adjustments to the CVR terms.

When is the new expiration date for the tender offer?

The tender offer has been extended to November 12, 2025.

What does LAVA's shareholder base need to do following the amendments?

LAVA shareholders who tendered their shares do not need to take any further action as their shares will remain part of the offer.

What conditions must be met for the acquisition to close?

The acquisition is contingent upon the tender of a significant percentage of shares and other customary closing conditions.

Why is the Extraordinary General Meeting important?

The EGM provides a forum for shareholders to discuss and vote on resolutions related to these significant transactions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Veterinary Biologics Growth Has a Valuable Catch Ahead

Updated Category News Views 124

Pet allergies and livestock disease are hardly glamorous, yet they are becoming a durable spending lane. The veterinary biologics market is projected to rise from $2.85 billion in 2026 to $3.69 billion by 2031, a 5.3% compound annual growth rate. That is not the kind of growth figure that makes anyone pound the table, and frankly it should not. It is the sort that can...

Continue Reading
Childcare Scale Makes Its Case, With Caveats Attached

Updated Category News Views 58

Childcare’s math is brutal before anybody starts arguing over ownership. Families need dependable hours, educators deserve better pay, and operators must keep buildings safe, staffed and open without pricing working parents clean out of the market. That is why this new Tyton Partners review of multi-site providers deserves a fair look, even if nobody should mistake a...

Continue Reading
Arizona's Dry Climate Puts Scalp Health Under Stress

Updated Category News Views 77

Desert weather is unforgiving, and apparently the scalp does not get a pass. In a Nov. 20, 2026 discussion, Scottsdale and Tucson hair-restoration physician Dr. Sharon A. Keene frames Arizona hair concerns around something easy to overlook: the condition of the skin beneath the hair. That is a more sensible starting point than treating every strand in the shower like it...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Franklin County Trees Raise Funds and Honor Veterans

Updated Category News Views 66

Holiday charity works best when it gives people something tangible to gather around, and Franklin County has found a pretty sturdy version of that formula. Its eighth annual Festival of Trees opens at 4 p.m. Saturday, November 21, at the Franklin County 11/30 Visitors Center in downtown Chambersburg, carrying the theme A Salute To Veterans. More than 80 decorated trees...

Continue Reading
KONST Pitches Asia GPU Uptime as AI Demand Gets Real

Updated Category News Views 115

GPU racks are easy to admire when the lights are on; keeping them useful at 3 a.m. is where the bruises show. KONST arrived at SC26 in Chicago with a sensible pitch for an AI-infrastructure market that is getting less impressed by shiny hardware lists and more obsessed with whether the thing actually works. Its theme, “24/7 GPUs Delivered in Asia,” puts the emphasis...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 95

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 268

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading
Trade Secret Damages Turn on Corporate Intent Evidence

Updated Category News Views 101

Suspicion may rattle a courtroom, but it apparently does not always loosen the jury’s purse strings. That is the useful, slightly sobering takeaway from DOAR’s new national study on damages in trade secret disputes, released November 20, 2026. Jurors, according to the report, draw a meaningful line between an employee carrying experience to a new job and a company...

Continue Reading

Top 5 Most Recently Viewed Articles

Freddie Mac's 30-Year Mortgage Rate Decreases Slightly

Updated Category News Views 219

Freddie Mac Reports on Mortgage Rates In recent reports from Freddie Mac, there's good news for potential homebuyers. The 30-year fixed-rate mortgage (FRM) has seen a slight decline, which is a welcome change in a fluctuating market. This current value sits at an average of 6.64%, reflecting a small drop from the previous week's average of 6.65%. Understanding the Current...

Continue Reading
Sports.com Partners with SEGG Media for Soccerex Event

Updated Category News Views 251

Sports.com Joins SEGG Media as Title Sponsor at Soccerex Miami 2025 MIAMI BEACH, Fla. — SEGG Media Corporation (NASDAQ: SEGG, LTRYW) has officially announced that Sports.com will take on the role of Title Sponsor for the engaging Soccerex Miami event happening at the Miami Beach Convention Center. This sponsorship reflects a significant commitment to promoting...

Continue Reading
Gastech 2025: A Global Convergence for Energy Innovations

Updated Category News Views 249

Gastech 2025 Unites the World of Energy Innovation Gastech 2025 welcomes more than 50,000 attendees from over 150 countries, establishing Milan as the global center for critical dialogues on energy supply, transformation, and innovation. This event has become a vital platform for high-level conversations that shape the future of energy. Leadership at Gastech 2025...

Continue Reading
Baird Confirms Outperform Rating for Costco Amidst Strong Growth

Updated Category News Views 68

Strong Sales Performance Driving Costco's Success Baird has reaffirmed its Outperform rating for Costco Wholesale (NASDAQ: COST), while upholding a price target of $975. The firm's latest insights indicate that Costco's global core comparable sales, excluding gas and foreign exchange influences, have surged by 8.9%. Such a rise is significant and demonstrates the...

Continue Reading
Celebrating a Decade of DNBSEQ™: Innovations and Impact

Updated Category News Views 290

Celebrating a Decade of DNBSEQ™ Technology MGI Tech Co., Ltd. (NASDAQ: MGI) is thrilled to celebrate ten years of its revolutionary DNBSEQ™ sequencing technology. This milestone marks a significant journey in transforming the landscape of genomics, offering solutions that not only enhance scientific research but also make genomic information more accessible to a...

Continue Reading